Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys

被引:65
作者
Zhang, ZM
Andersen, AH
Avison, MJ
Gerhardt, GA
Gash, DM
机构
[1] Univ Kentucky, Med Ctr, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA
[2] Univ Kentucky, Coll Med, Magnet Resonance Imaging & Spect Ctr, Lexington, KY 40536 USA
[3] Univ Kentucky, Coll Med, Dept Neurol, Lexington, KY 40536 USA
关键词
fMRI; rhesus monkey; basal ganglia; apomorphine; isoflurane anesthesia;
D O I
10.1016/S0006-8993(99)02243-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Functional magnetic resonance imaging (fMRI) was used to analyze blood oxygen level-dependent (BOLD) responses in the nigrostriatal system (caudate nucleus, putamen and substantia nigra) of awake rhesus monkeys to systemic apomorphine administration. The study (1) measured BOLD responses as an index of neuronal activity in the three structures following injections of the mixed D1/D2 agonist, and (2) assessed the effects of isoflurane anesthesia on the fMRI responses. Compared to control saline injections, 0.1 mg/kg apomorphine significantly activated the caudate nucleus (P less than or equal to 0.005), putamen (P less than or equal to 0.001) and substantia nigra (P less than or equal to 0.005). The responses were consistent with activation of GABAergic neurons in these three structures seen in other animal models. Isoflurane gas measurably blunted the response to apomorphine, so that a significant apomorphine activation was only seen in the substantia nigra of anesthetized animals. Even there, the mean MR signal change was reduced from 9.8% in awake monkeys to 2.3% in anesthetized animals. The data support the hypothesis that fMRI can be used to study the effects of drugs that alter basal ganglia activity in awake rhesus monkeys. (C) 2000 Published by Elsevier Science B.V, All rights reserved.
引用
收藏
页码:290 / 296
页数:7
相关论文
共 50 条
  • [11] Functional anatomy of the basal ganglia
    Luquin, MR
    JimenezJimenez, FJ
    REVISTA DE NEUROLOGIA, 1997, 25 : S121 - S128
  • [12] Functional anatomy of the basal ganglia
    Merello, M
    Cammarota, A
    REVISTA DE NEUROLOGIA, 2000, 30 (11) : 1055 - 1060
  • [13] An MRI atlas of the mouse basal ganglia
    Jeremy F. P. Ullmann
    Charles Watson
    Andrew L. Janke
    Nyoman D. Kurniawan
    George Paxinos
    David C. Reutens
    Brain Structure and Function, 2014, 219 : 1343 - 1353
  • [14] The development of the basal ganglia in Capuchin monkeys (Cebus apella)
    Phillips, Kimberley A.
    Sobieski, Courtney A.
    Gilbert, Valerie R.
    Chiappini-Williamson, Christine
    Sherwood, Chet C.
    Strick, Peter L.
    BRAIN RESEARCH, 2010, 1329 : 82 - 88
  • [15] Pharmacological MRI (phMRI) monitoring of treatment in hemiparkinsonian rhesus monkeys
    Luan, Liming
    Ding, Feng
    Ai, Yi
    Andersen, Anders
    Hardy, Peter
    Forman, Eric
    Gerhardt, Greg A.
    Gash, Don M.
    Grondin, Richard
    Zhang, Zhiming
    CELL TRANSPLANTATION, 2008, 17 (04) : 417 - 425
  • [16] APOMORPHINE FACILITATES MALE SEXUAL-BEHAVIOR OF RHESUS-MONKEYS
    POMERANTZ, SM
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 35 (03) : 659 - 664
  • [17] Perineuronal nets in the rhesus monkey and human basal forebrain including basal ganglia
    Adams, I
    Brauer, K
    Arélin, C
    Härtig, W
    Fine, A
    Mäder, M
    Arendt, T
    Brückner, G
    NEUROSCIENCE, 2001, 108 (02) : 285 - 298
  • [18] Basal ganglia and gait control: apomorphine administration and internal pallidum stimulation in Parkinson's disease
    Grasso, R
    Peppe, A
    Stratta, F
    Angelini, D
    Zago, M
    Stanzione, P
    Lacquaniti, F
    EXPERIMENTAL BRAIN RESEARCH, 1999, 126 (02) : 139 - 148
  • [19] Basal ganglia and gait control: apomorphine administration and internal pallidum stimulation in Parkinson’s disease
    R. Grasso
    A. Peppe
    F. Stratta
    D. Angelini
    M. Zago
    P. Stanzione
    F. Lacquaniti
    Experimental Brain Research, 1999, 126 : 139 - 148
  • [20] Normal functional imaging of the basal ganglia
    Lehéricy, S
    Gerardin, E
    EPILEPTIC DISORDERS, 2002, 4 : S23 - S30